Clinical Research Studies

research studies

Click to add your name to the waiting list for upcoming healthy studies. We will alert you when we begin a new healthy study. Please provide your email address if possible.

*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*

Schizophrenia Study

wHAT IF USING YOUR PHONE COULD IMPROVE YOUR SCHIZOPHRENIA SYMPTOMS?

The purpose of this study is to see if using a smartphone app (named “CT-155”) can help treat your schizophrenia symptoms and improve your quality of life while continuing your typical care including medications and behavioral therapies. The CT-155 app is an investigational digital therapy. It includes daily interactive lessons, guidance on practicing new skills (e.g., relaxation, positive thinking, being social), setting of personal goals, mood check-ins, and completion of educational activities.

Take the next step

To see if you might qualify for the study, please click Study Details and fill out the brief questionnaire

Bipolar I study

Is Bipolar I depression affecting your child or teen?

The purpose of this study is to look into the safety and efficacy of cariprazine in the treatment of bipolar depression for children. Cariprazine is approved in the United States by the US Food and Drug Administration (FDA) for the treatment of bipolar depression in adults, however, has only been studied in a limited number of children under 18 years of age. As the safety and effectiveness of cariprazine in children under 18 years of age has not been established, cariprazine is not currently approved by the FDA for use in children and therefore its use in this study is investigational (being tested).

Take the next step

To see if you might qualify for the study, please click Study Details and fill out the brief questionnaire

major depressive disorder study

Are you diagnosed with major depressive disorder?

SEP-363856 is being studied as a possible treatment for major depressive disorder when added to an approved antidepressant therapy (ADT).

You are invited to take part in this research study as you are suffering from a major depressive disorder. The reason for this study is to find out the potential benefits and safety of SEP-363856.

Take the next step

To see if you might qualify for the study, please click Study Details and fill out the brief questionnaire

opioid use disorder study

Still Struggling with Opioid Use Disorder?

Opioid use disorder (OUD) is a chronic disease of the brain sometimes called opioid addiction characterised by the continual use of opioids despite harmful consequences caused by their use. OUD may involve physical dependence (where withdrawal can cause symptoms such as aches, pains, and nausea) and psychological dependence (where withdrawal can cause symptoms such as strong cravings for the substance or affect behaviour and difficulty thinking about anything else). INDV-2000 is a non-opioid drug being developed for treatment of OUD. INDV-2000 works by binding to proteins in the brain called orexin-1 (OX1R) receptors, which may help treat opioid dependency by reducing craving, relapse, and symptoms of withdrawal. INDV-2000 is an extended-release tablet taken by mouth once every day.

Take the next step

To see if you might qualify for the study, please click Study Details and fill out the brief questionnaire